The adrenal glands are small endocrine organs that sit atop the kidneys and regulate critical bodily functions through hormone release. This evergreen explainer covers adrenal anatomy, physiology, and key disorders such as adrenal insufficiency and Cushing’s syndrome, emphasizing how tests and treatments work in practice. It is designed for clinicians and informed readers who want an accurate, up-to-date summary of adrenal health without unnecessary hype.
Basic Anatomy and Physiology
The adrenal glands consist of two distinct parts: the outer cortex and the inner medulla. The cortex produces glucocorticoids (mainly cortisol), mineralocorticoids (mainly aldosterone), and small amounts of androgens. These hormones regulate stress response, blood pressure, electrolyte balance, and metabolism. The medulla produces catecholamines such as epinephrine and norepinephrine, which support rapid fight-or-flight responses. Regulation occurs primarily through the hypothalamic–pituitary–adrenal (HPA) axis, where corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) control cortisol output on a daily and stress-driven basis.
Common Adrenal Conditions
Several conditions can impair adrenal function. Adrenal insufficiency, also called Addison disease, occurs when the glands do not produce enough cortisol and often aldosterone as well. Causes include autoimmune destruction, infections, hemorrhage, and secondary causes related to pituitary or hypothalamic dysfunction. Cushing’s syndrome involves prolonged excess cortisol, which can arise from exogenous medication, a pituitary adenoma (Cushing disease), or adrenal tumors. Other clinical issues include pheochromocytoma (a catecholamine-secreting tumor) and aldosterone-producing adenomas, which can cause hypertension and potassium loss.
Adrenal Insufficiency Overview
In primary adrenal insufficiency, cortisol and often aldosterone are low due to gland damage. In secondary adrenal insufficiency, ACTH output from the pituitary is reduced, leading to low cortisol but usually preserved aldosterone. Symptoms may include fatigue, weight loss, hypotension, hyperpigmentation (primary), salt craving, and hypoglycemia. Diagnosis combines clinical evaluation with dynamic tests that assess the HPA axis, such as the ACTH stimulation test and insulin tolerance test.
Cushing’s Syndrome and Associated Features
Hypercortisolism can present with central obesity, moon face, buffalo hump, skin thinning, bruising, hypertension, and glucose intolerance. Confirmatory testing typically starts with screening tests like 24-hour urinary free cortisol, late-night salivary cortisol, or a low-dose dexamethasone suppression test. Once biochemical hypercortisolism is established, further imaging and testing help localize the source. Distinguishing between ACTH-dependent and ACTH-independent causes is essential for guiding treatment.
Adrenal Testing Approaches
No single test is adequate in all contexts; clinicians select tests based on symptoms, medication use, and pretest probability. Key tools include basal morning ACTH and cortisol, dynamic function tests, and, when appropriate, imaging such as CT or MRI of the adrenals. Interpretation must account for medications, circadian rhythm, and comorbid conditions. Collaborating with endocrinology is often necessary when results are equivocal or when complex management is required.
Typical Hormone Panels and Clinical Context
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Morning Cortisol | Usually highest around 8 AM in healthy individuals | Clinical Guideline |
| ACTH | Drives cortisol production by the adrenal cortex | Physiology Reference |
| 24-hour Urinary Free Cortisol | Used to screen for Cushing’s syndrome | Clinical Testing Resource |
| Late-Night Salivary Cortisol | Helps assess loss of normal diurnal rhythm | Clinical Guideline |
| ACTH Stimulation Test | Assesses adrenal reserve by measuring cortisol response | Endocrine Society Guidance |
| Imaging (CT/MRI) | Localization after biochemical confirmation of a disorder | Imaging Best Practice |
Symptom Patterns and Clinical Considerations
Because adrenal disorders can be nonspecific, recognition relies on a high index of suspicion. Fatigue, muscle weakness, weight changes, and mood disturbances overlap with many other conditions. Orthostatic symptoms and electrolyte abnormalities raise concern for mineralocorticoid deficiency or excess. A careful medication history is crucial, as glucocorticoids can suppress the HPA axis and complicate interpretation of test results. When in doubt, endocrinology referral enables tailored testing and safe monitoring.
Treatment and Long-term Management
Management depends on the underlying cause. Patients with adrenal insufficiency generally require glucocorticoid replacement, often with a physiologic dosing schedule, and mineralocorticoid replacement when aldosterone is deficient. Education about sick-day rules, stress-dose adjustments, and emergency injectable corticosteroids is essential. For Cushing’s syndrome, treatment targets the source of excess cortisol and may involve surgery, radiation, or pharmacologic therapy. Pheochromocytoma is typically managed with surgical resection after appropriate alpha- and beta-blockade. Long-term follow-up includes monitoring hormone levels, growth and bone health in children, and surveillance for associated conditions or recurrence.
Limitations and Evolving Understanding
Interpretation of adrenal tests can be influenced by timing, medications, and comorbid illness, and reference ranges vary by assay. Controversies remain around optimal screening strategies in certain populations and the best approaches for managing subclinical abnormalities. Research continues to refine diagnostic criteria and treatment algorithms. This overview reflects current understanding but should be integrated with clinical judgment and updated guidelines as new evidence emerges.
Summary and Practical Takeaways
The adrenal glands play a central role in stress adaptation, electrolyte balance, and metabolism. Key disorders such as adrenal insufficiency and Cushing’s syndrome have distinct clinical features and diagnostic pathways. Testing strategies are guided by clinical context, and results often require multidisciplinary interpretation. Management includes hormone replacement, treatment of the underlying cause, and ongoing monitoring. For sustainable care, clinicians and patients should maintain a clear understanding of physiologic principles, limitations of testing, and the importance of individualized follow-up.